Full Product Name
BRCA2 Polyclonal Antibody
Product Synonym Names
FAD; FACD; FAD1; GLM3; BRCC2; FANCB; FANCD; PNCA2; FANCD1; BROVCA2
Product Gene Name
anti-BRCA2 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Purity/Purification
Antigen Affinity Purification
Concentration
2.7mg/ml (lot specific)
Immunogen
Synthetic peptide of human BRCA2
Buffer
PBS with 0.05% sodium azide, 50% glycerol, pH7.3
Santa Cruz Alternative
Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-21177 / sc-1819 / sc-1817 / sc-1818 / sc-21230 / sc-1816 / sc-8326 / sc-28235
Preparation and Storage
Store at -20 degree C. Avoid freeze/thaw cycles.
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Other Notes
Small volumes of anti-BRCA2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-BRCA2 antibody
Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele.
Applications Tested/Suitable for anti-BRCA2 antibody
ELISA (EIA), Immunohistochemistry (IHC)
Application Notes for anti-BRCA2 antibody
ELISA: 1:2000-5000
IHC: 1:25-100
Immunohistochemistry (IHC) of anti-BRCA2 antibody
Immunohistochemistry of paraffin-embedded Human lung cancer tissue using BRCA2 Polyclonal Antibody at dilution 1:35

NCBI/Uniprot data below describe general gene information for BRCA2. It may not necessarily be applicable to this product.
UniProt Secondary Accession #
O00183; O15008; Q13879; Q5TBJ7[Other Products]
UniProt Related Accession #
P51587[Other Products]
Molecular Weight
384,202 Da
NCBI Official Full Name
BRCA2
NCBI Official Synonym Full Names
BRCA2, DNA repair associated
NCBI Official Symbol
BRCA2??[Similar Products]
NCBI Official Synonym Symbols
FAD; FACD; FAD1; GLM3; BRCC2; FANCD; PNCA2; FANCD1; XRCC11; BROVCA2
??[Similar Products]
NCBI Protein Information
breast cancer type 2 susceptibility protein
UniProt Protein Name
Breast cancer type 2 susceptibility protein
UniProt Synonym Protein Names
Fanconi anemia group D1 protein
Protein Family
BRCA2 and CDKN1A-interacting protein
UniProt Gene Name
BRCA2??[Similar Products]
UniProt Synonym Gene Names
FACD; FANCD1??[Similar Products]
UniProt Entry Name
BRCA2_HUMAN
NCBI Summary for BRCA2
Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, Dec 2008]
UniProt Comments for BRCA2
BRCA2: involved in double-strand break repair and/or homologous recombination. May participate in S phase checkpoint activation. Interacts with RAD51 and DSS1. Interacts with ubiquitinated FANCD2. Interacts with PALB2, enables the recombinational repair and checkpoint functions. Interacts with WDR16. Defects in BRCA2 are a cause of genetic susceptibility to breast cancer and may underlie susceptibility to uveal melanoma.
Protein type: DNA repair, damage; Nuclear receptor co-regulator; Tumor suppressor
Chromosomal Location of Human Ortholog: 13q12.3
Cellular Component: BRCA2-MAGE-D1 complex; centrosome; cytoplasm; lateral element; nuclear chromosome, telomeric region; nucleoplasm; nucleus; protein complex; secretory granule
Molecular Function: gamma-tubulin binding; H3 histone acetyltransferase activity; H4 histone acetyltransferase activity; histone acetyltransferase activity; protease binding; protein binding; protein C-terminus binding; single-stranded DNA binding
Biological Process: centrosome duplication; cytokinesis; DNA synthesis during DNA repair; double-strand break repair; double-strand break repair via homologous recombination; negative regulation of mammary gland epithelial cell proliferation; nucleotide-excision repair; positive regulation of transcription, DNA-dependent; strand displacement
Disease: Breast Cancer; Breast-ovarian Cancer, Familial, Susceptibility To, 2; Fanconi Anemia, Complementation Group D1; Glioma Susceptibility 3; Medulloblastoma; Pancreatic Cancer, Susceptibility To, 2; Prostate Cancer; Tracheoesophageal Fistula With Or Without Esophageal Atresia; Wilms Tumor 1
Research Articles on BRCA2
1. Data show that 11 breast cancer patients were mutated in BRCA1/2 genes, and 29 were not associated to BRCA1/2 mutations.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.